Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HAEGARDA - Health Canada Drug Approval Details

Approvals/Health Canada/HAEGARDA

Authorized

STANDARD

HAEGARDA

csl behring canada inc🇨🇦 Health Canada

Approval Date: Jul 4, 2025
Approval ID: 395f12dbb26b172f
Company: csl behring canada inc
Type: Standard

Approval Details

Approval Id: 395f12dbb26b172f
Drug Approval Canada Name: HAEGARDA
Product Name: HAEGARDA
Status: Marketed
Status Date: 2020-01-23
Original Market Date: 2020-01-23
Din: 02468077
Drug Class: Human
Dosage Form: Powder For Solution , Kit
Route Of Administration: Subcutaneous
Schedule: Schedule D
Ahfs: 92:32.00
Atc Original: B06AC01 C1-INHIBITOR, PLASMA DERIVED
Atc Name: b 06 ac 01
Aig Number: 0152746004
Company Name: csl behring canada inc
Company Address: 350, 55 Metcalfe Street, Ottawa, Ontario, Canada, K1P 6L5

Active Ingredients

C1 ESTERASE INHIBITOR (HUMAN)

3000 UNIT / VIAL

Authorized

Quick Info

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

395f12dbb26b172f

Type

Standard

Back to Health Canada Approvals